Pharmacokinetics of chitobiose and chitotriose administered intravenously or orally to rats. 2005

An-Shu Chen, and Tadao Taguchi, and Hirokazu Okamoto, and Kazumi Danjo, and Kazuo Sakai, and Yoshiharu Matahira, and Min-Wei Wang, and Ichitomo Miwa
Department of Pathobiochemistry, Faculty of Pharmacy, Meijo University, Nagoya, Japan.

Chitooligosaccharides have attracted much attention as new biomedical materials. The biologic availability of each of these chitooligosaccharides, however, has not yet been studied. In the present study, we found that chitobiose and chitotriose appeared in the blood of rats with maximum plasma concentrations at around 1 h after administration when given orally at a dose of 30 mg/kg. However, chitotetraose and chitopentaose did not appear in the blood when given at a dose of 300 mg/kg. Pharmacokinetic analysis of chitobiose and chitotriose after intravenous administration at 100 mg/kg revealed that both sugars were eliminated from the body following a one-compartment model and that the former relative to the latter was higher for both the total body clearance (224+/-43 vs. 155+/-26 ml/h/kg) and the distribution volume (107+/-15 vs. 65+/-9 ml/kg). The absolute oral bioavailability of chitobiose was higher than that of chitotriose at all doses (30, 100, and 300 mg/kg) examined. The first-order absorption rate constants for chitobiose and chitotriose at all doses were less than 1.0 h(-1) and smaller than the elimination rate constants (2.2+/-0.3, 2.7+/-0.1 h(-1), respectively). The absorption was slow, resulting in flip-flop kinetics. This study indicates that among various chitooligosaccharides, only chitobiose and chitotriose can be appreciably absorbed from the gastrointestinal tract.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D004187 Disaccharides Oligosaccharides containing two monosaccharide units linked by a glycosidic bond. Disaccharide
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014312 Trisaccharides Oligosaccharides containing three monosaccharide units linked by glycosidic bonds. Trisaccharide
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

An-Shu Chen, and Tadao Taguchi, and Hirokazu Okamoto, and Kazumi Danjo, and Kazuo Sakai, and Yoshiharu Matahira, and Min-Wei Wang, and Ichitomo Miwa
February 2022, Bioresources and bioprocessing,
An-Shu Chen, and Tadao Taguchi, and Hirokazu Okamoto, and Kazumi Danjo, and Kazuo Sakai, and Yoshiharu Matahira, and Min-Wei Wang, and Ichitomo Miwa
March 1989, Journal of pharmaceutical sciences,
An-Shu Chen, and Tadao Taguchi, and Hirokazu Okamoto, and Kazumi Danjo, and Kazuo Sakai, and Yoshiharu Matahira, and Min-Wei Wang, and Ichitomo Miwa
June 2000, American journal of veterinary research,
An-Shu Chen, and Tadao Taguchi, and Hirokazu Okamoto, and Kazumi Danjo, and Kazuo Sakai, and Yoshiharu Matahira, and Min-Wei Wang, and Ichitomo Miwa
June 2007, International journal of pharmaceutics,
An-Shu Chen, and Tadao Taguchi, and Hirokazu Okamoto, and Kazumi Danjo, and Kazuo Sakai, and Yoshiharu Matahira, and Min-Wei Wang, and Ichitomo Miwa
April 1992, The Journal of antimicrobial chemotherapy,
An-Shu Chen, and Tadao Taguchi, and Hirokazu Okamoto, and Kazumi Danjo, and Kazuo Sakai, and Yoshiharu Matahira, and Min-Wei Wang, and Ichitomo Miwa
December 1992, American journal of veterinary research,
An-Shu Chen, and Tadao Taguchi, and Hirokazu Okamoto, and Kazumi Danjo, and Kazuo Sakai, and Yoshiharu Matahira, and Min-Wei Wang, and Ichitomo Miwa
May 2013, American journal of veterinary research,
An-Shu Chen, and Tadao Taguchi, and Hirokazu Okamoto, and Kazumi Danjo, and Kazuo Sakai, and Yoshiharu Matahira, and Min-Wei Wang, and Ichitomo Miwa
January 1993, European journal of drug metabolism and pharmacokinetics,
An-Shu Chen, and Tadao Taguchi, and Hirokazu Okamoto, and Kazumi Danjo, and Kazuo Sakai, and Yoshiharu Matahira, and Min-Wei Wang, and Ichitomo Miwa
October 1990, Journal of clinical pharmacology,
An-Shu Chen, and Tadao Taguchi, and Hirokazu Okamoto, and Kazumi Danjo, and Kazuo Sakai, and Yoshiharu Matahira, and Min-Wei Wang, and Ichitomo Miwa
October 1994, Journal of veterinary pharmacology and therapeutics,
Copied contents to your clipboard!